Use of mannitol in CT enterography with their side effects evaluation

An open label randomized clinical trial to evaluating the efficacy of mannitol & water as endoluminal contrast agent in CT enterography and preventive measure to reduce adverse drug reaction

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063015

Enrollment

500

Registered

2024-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Control Intervention1: Water , 1% mannitol , 2% mannitol , 3% mannitol ,3% mannitol with psyllium husk: These groups are divided into separate category and will be compared for effects in bowel study

Eligibility

Inclusion criteria

Inclusion criteria: Willing to complete the study.

Exclusion criteria

Exclusion criteria: Conditions like surgically altered bowel , stenosis , strictures , inflammatory bowel disease, gross ascites & bowel carcinoma that can cause bias in study result

Design outcomes

Primary

Measure	Time frame
Mannitol in CT enterography and comparing side effects of various concentration of mannitolTimepoint: within 48 hours of study performed	—

Secondary

Measure	Time frame
Using 1 liter of water after CT , using psyllium husk along with mannitol to increase tolerance for mannitolTimepoint: 48 hours after the study performed	—

Countries

India

Contacts

Public ContactDr Mariya

JN medical college , aligarh uttar pradesh

drmehtab@gmail.com9389908955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026